Continuous blood glucose monitoring by artificial pancreas during interventional radiology

Continuous blood glucose monitoring by artificial pancreas during interventional radiology - Blood Glucose Monitoring by Artificial Pancreas -InterVentional Radiology (GMAP-IVR)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012309

Enrollment

Registered

2013-11-18

Start date

2013-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients treated intra- and extracranial diseases (aneurysms, arterial stenosis, and tumors, etc.)with interventional radiology

Interventions

During IVR, blood glucose is continuously monitored by artificial pancreas. Blood is sampled at a 2mL/hr from peripheral vein.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diseases required IVR Men and women of 20 years of age or older Unnecessary of insulin treatment Written Informed consent

Exclusion criteria

Exclusion criteria: Necessary of insulin treatment Requirement of glucose administration before and during surgery Pregnant or lactating women and women of child bearing potential Patients judged by investigators ineligible for participation as study subjects for any other reason.

Design outcomes

Primary

Measure	Time frame
Correlation between blood glucose change and adverse event during IVR	—

Secondary

Measure	Time frame
Correlation between hypreintense lesions on postoperative diffusion weighted images and blood glucose change Correlation between change of cerebral blood flow on postoperative SPECT and blood glucose change Incidence of unmeasurable events	—

Countries

Japan

Contacts

Public ContactMotomasa Furuse

Osaka Medical College Neurosurgery

neu054@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026